secwatch.observer — SEC 8-K summary
======================================

Issuer:     PETMED EXPRESS INC (PETS)
CIK:        0001040130
Form:       8-K
Filed at:   2023-01-17T23:59:59+00:00
Accession:  0001040130-23-000003
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PetMeds acquires PetCareRx for $36M cash; adds ~200K customers, ~$42M revenue
-----------------------------------------------------------------------------

- All-cash deal $36M plus working capital adjustments; expected close Q1 2023.
- PetCareRx contributed ~$42M revenue (12 mo. to Oct 2022) and ~200K customers.
- Deal adds ~10K incremental wellness products; PetMeds will keep PetCareRx brand separate.
- Boards of both companies approved; conditions include regulatory and pharmacy license filings.
- Second major transaction in 9 months; follows Vetster investment in Apr 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1040130/000104013023000003/0001040130-23-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1040130/000104013023000003/pets-20230113.htm
  HTML page:      https://secwatch.observer/filing/0001040130-23-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer